Loading...
Poor Outcomes in Elderly Kidney Transplant Recipients Receiving Alemtuzumab Induction
INTRODUCTION: Alemtuzumab and rabbit antithymocyte globulin (rATG) are being used with increasing frequency as induction agents in kidney transplantation. Using the US Renal Data Base System, we analyzed the safety profile of these agents in the elderly. METHODS: In a cohort of patients transplanted...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger AG
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3237278/ https://ncbi.nlm.nih.gov/pubmed/22104284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000334092 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|